Global Live Attenuated Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Live Attenuated Vaccines market size was valued at USD 26690 million in 2023 and is forecast to a readjusted size of USD 39700 million by 2030 with a CAGR of 5.8% during review period.
An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or 'live'). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by 'killing' the virus (inactivated vaccine).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Live Attenuated Vaccines industry chain, the market status of Hospitals (Bacterial, Viral), Clinics (Bacterial, Viral), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Live Attenuated Vaccines.
Regionally, the report analyzes the Live Attenuated Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Live Attenuated Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Live Attenuated Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Live Attenuated Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Bacterial, Viral).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Live Attenuated Vaccines market.
Regional Analysis: The report involves examining the Live Attenuated Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Live Attenuated Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Live Attenuated Vaccines:
Company Analysis: Report covers individual Live Attenuated Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Live Attenuated Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Live Attenuated Vaccines. It assesses the current state, advancements, and potential future developments in Live Attenuated Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Live Attenuated Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Live Attenuated Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Live Attenuated Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Live Attenuated Vaccines, with price, sales, revenue and global market share of Live Attenuated Vaccines from 2019 to 2024.
Chapter 3, the Live Attenuated Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Live Attenuated Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Live Attenuated Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Live Attenuated Vaccines.
Chapter 14 and 15, to describe Live Attenuated Vaccines sales channel, distributors, customers, research findings and conclusion.
An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or 'live'). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by 'killing' the virus (inactivated vaccine).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Live Attenuated Vaccines industry chain, the market status of Hospitals (Bacterial, Viral), Clinics (Bacterial, Viral), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Live Attenuated Vaccines.
Regionally, the report analyzes the Live Attenuated Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Live Attenuated Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Live Attenuated Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Live Attenuated Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Bacterial, Viral).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Live Attenuated Vaccines market.
Regional Analysis: The report involves examining the Live Attenuated Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Live Attenuated Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Live Attenuated Vaccines:
Company Analysis: Report covers individual Live Attenuated Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Live Attenuated Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Live Attenuated Vaccines. It assesses the current state, advancements, and potential future developments in Live Attenuated Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Live Attenuated Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Live Attenuated Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Bacterial
- Viral
- Hospitals
- Clinics
- Research Institutes
- Others
- GlaxoSmithKline
- Merck
- Pfizer
- Astellas Pharma
- Johnson & Johnson
- CSL
- Sanofi
- Serum Institute Of India
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Live Attenuated Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Live Attenuated Vaccines, with price, sales, revenue and global market share of Live Attenuated Vaccines from 2019 to 2024.
Chapter 3, the Live Attenuated Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Live Attenuated Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Live Attenuated Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Live Attenuated Vaccines.
Chapter 14 and 15, to describe Live Attenuated Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Live Attenuated Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Live Attenuated Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Bacterial
1.3.3 Viral
1.4 Market Analysis by Application
1.4.1 Overview: Global Live Attenuated Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Research Institutes
1.4.5 Others
1.5 Global Live Attenuated Vaccines Market Size & Forecast
1.5.1 Global Live Attenuated Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Live Attenuated Vaccines Sales Quantity (2019-2030)
1.5.3 Global Live Attenuated Vaccines Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Live Attenuated Vaccines Product and Services
2.1.4 GlaxoSmithKline Live Attenuated Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GlaxoSmithKline Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Live Attenuated Vaccines Product and Services
2.2.4 Merck Live Attenuated Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck Recent Developments/Updates
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Live Attenuated Vaccines Product and Services
2.3.4 Pfizer Live Attenuated Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Pfizer Recent Developments/Updates
2.4 Astellas Pharma
2.4.1 Astellas Pharma Details
2.4.2 Astellas Pharma Major Business
2.4.3 Astellas Pharma Live Attenuated Vaccines Product and Services
2.4.4 Astellas Pharma Live Attenuated Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Astellas Pharma Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Live Attenuated Vaccines Product and Services
2.5.4 Johnson & Johnson Live Attenuated Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 CSL
2.6.1 CSL Details
2.6.2 CSL Major Business
2.6.3 CSL Live Attenuated Vaccines Product and Services
2.6.4 CSL Live Attenuated Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 CSL Recent Developments/Updates
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Live Attenuated Vaccines Product and Services
2.7.4 Sanofi Live Attenuated Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sanofi Recent Developments/Updates
2.8 Serum Institute Of India
2.8.1 Serum Institute Of India Details
2.8.2 Serum Institute Of India Major Business
2.8.3 Serum Institute Of India Live Attenuated Vaccines Product and Services
2.8.4 Serum Institute Of India Live Attenuated Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Serum Institute Of India Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: LIVE ATTENUATED VACCINES BY MANUFACTURER
3.1 Global Live Attenuated Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Live Attenuated Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Live Attenuated Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Live Attenuated Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Live Attenuated Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Live Attenuated Vaccines Manufacturer Market Share in 2023
3.5 Live Attenuated Vaccines Market: Overall Company Footprint Analysis
3.5.1 Live Attenuated Vaccines Market: Region Footprint
3.5.2 Live Attenuated Vaccines Market: Company Product Type Footprint
3.5.3 Live Attenuated Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Live Attenuated Vaccines Market Size by Region
4.1.1 Global Live Attenuated Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Live Attenuated Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Live Attenuated Vaccines Average Price by Region (2019-2030)
4.2 North America Live Attenuated Vaccines Consumption Value (2019-2030)
4.3 Europe Live Attenuated Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Live Attenuated Vaccines Consumption Value (2019-2030)
4.5 South America Live Attenuated Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Live Attenuated Vaccines Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Live Attenuated Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Live Attenuated Vaccines Consumption Value by Type (2019-2030)
5.3 Global Live Attenuated Vaccines Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Live Attenuated Vaccines Sales Quantity by Application (2019-2030)
6.2 Global Live Attenuated Vaccines Consumption Value by Application (2019-2030)
6.3 Global Live Attenuated Vaccines Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Live Attenuated Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Live Attenuated Vaccines Sales Quantity by Application (2019-2030)
7.3 North America Live Attenuated Vaccines Market Size by Country
7.3.1 North America Live Attenuated Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Live Attenuated Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Live Attenuated Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Live Attenuated Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe Live Attenuated Vaccines Market Size by Country
8.3.1 Europe Live Attenuated Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Live Attenuated Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Live Attenuated Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Live Attenuated Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Live Attenuated Vaccines Market Size by Region
9.3.1 Asia-Pacific Live Attenuated Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Live Attenuated Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Live Attenuated Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Live Attenuated Vaccines Sales Quantity by Application (2019-2030)
10.3 South America Live Attenuated Vaccines Market Size by Country
10.3.1 South America Live Attenuated Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Live Attenuated Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Live Attenuated Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Live Attenuated Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Live Attenuated Vaccines Market Size by Country
11.3.1 Middle East & Africa Live Attenuated Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Live Attenuated Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Live Attenuated Vaccines Market Drivers
12.2 Live Attenuated Vaccines Market Restraints
12.3 Live Attenuated Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Live Attenuated Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Live Attenuated Vaccines
13.3 Live Attenuated Vaccines Production Process
13.4 Live Attenuated Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Live Attenuated Vaccines Typical Distributors
14.3 Live Attenuated Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Live Attenuated Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Live Attenuated Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Bacterial
1.3.3 Viral
1.4 Market Analysis by Application
1.4.1 Overview: Global Live Attenuated Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Research Institutes
1.4.5 Others
1.5 Global Live Attenuated Vaccines Market Size & Forecast
1.5.1 Global Live Attenuated Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Live Attenuated Vaccines Sales Quantity (2019-2030)
1.5.3 Global Live Attenuated Vaccines Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Live Attenuated Vaccines Product and Services
2.1.4 GlaxoSmithKline Live Attenuated Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GlaxoSmithKline Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Live Attenuated Vaccines Product and Services
2.2.4 Merck Live Attenuated Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck Recent Developments/Updates
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Live Attenuated Vaccines Product and Services
2.3.4 Pfizer Live Attenuated Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Pfizer Recent Developments/Updates
2.4 Astellas Pharma
2.4.1 Astellas Pharma Details
2.4.2 Astellas Pharma Major Business
2.4.3 Astellas Pharma Live Attenuated Vaccines Product and Services
2.4.4 Astellas Pharma Live Attenuated Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Astellas Pharma Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Live Attenuated Vaccines Product and Services
2.5.4 Johnson & Johnson Live Attenuated Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 CSL
2.6.1 CSL Details
2.6.2 CSL Major Business
2.6.3 CSL Live Attenuated Vaccines Product and Services
2.6.4 CSL Live Attenuated Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 CSL Recent Developments/Updates
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Live Attenuated Vaccines Product and Services
2.7.4 Sanofi Live Attenuated Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sanofi Recent Developments/Updates
2.8 Serum Institute Of India
2.8.1 Serum Institute Of India Details
2.8.2 Serum Institute Of India Major Business
2.8.3 Serum Institute Of India Live Attenuated Vaccines Product and Services
2.8.4 Serum Institute Of India Live Attenuated Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Serum Institute Of India Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: LIVE ATTENUATED VACCINES BY MANUFACTURER
3.1 Global Live Attenuated Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Live Attenuated Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Live Attenuated Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Live Attenuated Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Live Attenuated Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Live Attenuated Vaccines Manufacturer Market Share in 2023
3.5 Live Attenuated Vaccines Market: Overall Company Footprint Analysis
3.5.1 Live Attenuated Vaccines Market: Region Footprint
3.5.2 Live Attenuated Vaccines Market: Company Product Type Footprint
3.5.3 Live Attenuated Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Live Attenuated Vaccines Market Size by Region
4.1.1 Global Live Attenuated Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Live Attenuated Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Live Attenuated Vaccines Average Price by Region (2019-2030)
4.2 North America Live Attenuated Vaccines Consumption Value (2019-2030)
4.3 Europe Live Attenuated Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Live Attenuated Vaccines Consumption Value (2019-2030)
4.5 South America Live Attenuated Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Live Attenuated Vaccines Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Live Attenuated Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Live Attenuated Vaccines Consumption Value by Type (2019-2030)
5.3 Global Live Attenuated Vaccines Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Live Attenuated Vaccines Sales Quantity by Application (2019-2030)
6.2 Global Live Attenuated Vaccines Consumption Value by Application (2019-2030)
6.3 Global Live Attenuated Vaccines Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Live Attenuated Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Live Attenuated Vaccines Sales Quantity by Application (2019-2030)
7.3 North America Live Attenuated Vaccines Market Size by Country
7.3.1 North America Live Attenuated Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Live Attenuated Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Live Attenuated Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Live Attenuated Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe Live Attenuated Vaccines Market Size by Country
8.3.1 Europe Live Attenuated Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Live Attenuated Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Live Attenuated Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Live Attenuated Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Live Attenuated Vaccines Market Size by Region
9.3.1 Asia-Pacific Live Attenuated Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Live Attenuated Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Live Attenuated Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Live Attenuated Vaccines Sales Quantity by Application (2019-2030)
10.3 South America Live Attenuated Vaccines Market Size by Country
10.3.1 South America Live Attenuated Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Live Attenuated Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Live Attenuated Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Live Attenuated Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Live Attenuated Vaccines Market Size by Country
11.3.1 Middle East & Africa Live Attenuated Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Live Attenuated Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Live Attenuated Vaccines Market Drivers
12.2 Live Attenuated Vaccines Market Restraints
12.3 Live Attenuated Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Live Attenuated Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Live Attenuated Vaccines
13.3 Live Attenuated Vaccines Production Process
13.4 Live Attenuated Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Live Attenuated Vaccines Typical Distributors
14.3 Live Attenuated Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 2. Global Live Attenuated Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Live Attenuated Vaccines Product and Services
Table 6. GlaxoSmithKline Live Attenuated Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GlaxoSmithKline Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Live Attenuated Vaccines Product and Services
Table 11. Merck Live Attenuated Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Merck Recent Developments/Updates
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Major Business
Table 15. Pfizer Live Attenuated Vaccines Product and Services
Table 16. Pfizer Live Attenuated Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Pfizer Recent Developments/Updates
Table 18. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Astellas Pharma Major Business
Table 20. Astellas Pharma Live Attenuated Vaccines Product and Services
Table 21. Astellas Pharma Live Attenuated Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Astellas Pharma Recent Developments/Updates
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Live Attenuated Vaccines Product and Services
Table 26. Johnson & Johnson Live Attenuated Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Johnson & Johnson Recent Developments/Updates
Table 28. CSL Basic Information, Manufacturing Base and Competitors
Table 29. CSL Major Business
Table 30. CSL Live Attenuated Vaccines Product and Services
Table 31. CSL Live Attenuated Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. CSL Recent Developments/Updates
Table 33. Sanofi Basic Information, Manufacturing Base and Competitors
Table 34. Sanofi Major Business
Table 35. Sanofi Live Attenuated Vaccines Product and Services
Table 36. Sanofi Live Attenuated Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sanofi Recent Developments/Updates
Table 38. Serum Institute Of India Basic Information, Manufacturing Base and Competitors
Table 39. Serum Institute Of India Major Business
Table 40. Serum Institute Of India Live Attenuated Vaccines Product and Services
Table 41. Serum Institute Of India Live Attenuated Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Serum Institute Of India Recent Developments/Updates
Table 43. Global Live Attenuated Vaccines Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 44. Global Live Attenuated Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 45. Global Live Attenuated Vaccines Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 46. Market Position of Manufacturers in Live Attenuated Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 47. Head Office and Live Attenuated Vaccines Production Site of Key Manufacturer
Table 48. Live Attenuated Vaccines Market: Company Product Type Footprint
Table 49. Live Attenuated Vaccines Market: Company Product Application Footprint
Table 50. Live Attenuated Vaccines New Market Entrants and Barriers to Market Entry
Table 51. Live Attenuated Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Live Attenuated Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 53. Global Live Attenuated Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 54. Global Live Attenuated Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 55. Global Live Attenuated Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 56. Global Live Attenuated Vaccines Average Price by Region (2019-2024) & (USD/Unit)
Table 57. Global Live Attenuated Vaccines Average Price by Region (2025-2030) & (USD/Unit)
Table 58. Global Live Attenuated Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 59. Global Live Attenuated Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 60. Global Live Attenuated Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Global Live Attenuated Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Global Live Attenuated Vaccines Average Price by Type (2019-2024) & (USD/Unit)
Table 63. Global Live Attenuated Vaccines Average Price by Type (2025-2030) & (USD/Unit)
Table 64. Global Live Attenuated Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 65. Global Live Attenuated Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 66. Global Live Attenuated Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 67. Global Live Attenuated Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 68. Global Live Attenuated Vaccines Average Price by Application (2019-2024) & (USD/Unit)
Table 69. Global Live Attenuated Vaccines Average Price by Application (2025-2030) & (USD/Unit)
Table 70. North America Live Attenuated Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 71. North America Live Attenuated Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 72. North America Live Attenuated Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 73. North America Live Attenuated Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 74. North America Live Attenuated Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 75. North America Live Attenuated Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 76. North America Live Attenuated Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 77. North America Live Attenuated Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Europe Live Attenuated Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 79. Europe Live Attenuated Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 80. Europe Live Attenuated Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 81. Europe Live Attenuated Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 82. Europe Live Attenuated Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 83. Europe Live Attenuated Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 84. Europe Live Attenuated Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Live Attenuated Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Live Attenuated Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 87. Asia-Pacific Live Attenuated Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 88. Asia-Pacific Live Attenuated Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 89. Asia-Pacific Live Attenuated Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 90. Asia-Pacific Live Attenuated Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 91. Asia-Pacific Live Attenuated Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 92. Asia-Pacific Live Attenuated Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 93. Asia-Pacific Live Attenuated Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 94. South America Live Attenuated Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 95. South America Live Attenuated Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 96. South America Live Attenuated Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 97. South America Live Attenuated Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 98. South America Live Attenuated Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 99. South America Live Attenuated Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 100. South America Live Attenuated Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America Live Attenuated Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa Live Attenuated Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 103. Middle East & Africa Live Attenuated Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 104. Middle East & Africa Live Attenuated Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 105. Middle East & Africa Live Attenuated Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 106. Middle East & Africa Live Attenuated Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 107. Middle East & Africa Live Attenuated Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 108. Middle East & Africa Live Attenuated Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Middle East & Africa Live Attenuated Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 110. Live Attenuated Vaccines Raw Material
Table 111. Key Manufacturers of Live Attenuated Vaccines Raw Materials
Table 112. Live Attenuated Vaccines Typical Distributors
Table 113. Live Attenuated Vaccines Typical Customers
Table 2. Global Live Attenuated Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Live Attenuated Vaccines Product and Services
Table 6. GlaxoSmithKline Live Attenuated Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GlaxoSmithKline Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Live Attenuated Vaccines Product and Services
Table 11. Merck Live Attenuated Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Merck Recent Developments/Updates
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Major Business
Table 15. Pfizer Live Attenuated Vaccines Product and Services
Table 16. Pfizer Live Attenuated Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Pfizer Recent Developments/Updates
Table 18. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Astellas Pharma Major Business
Table 20. Astellas Pharma Live Attenuated Vaccines Product and Services
Table 21. Astellas Pharma Live Attenuated Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Astellas Pharma Recent Developments/Updates
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Live Attenuated Vaccines Product and Services
Table 26. Johnson & Johnson Live Attenuated Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Johnson & Johnson Recent Developments/Updates
Table 28. CSL Basic Information, Manufacturing Base and Competitors
Table 29. CSL Major Business
Table 30. CSL Live Attenuated Vaccines Product and Services
Table 31. CSL Live Attenuated Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. CSL Recent Developments/Updates
Table 33. Sanofi Basic Information, Manufacturing Base and Competitors
Table 34. Sanofi Major Business
Table 35. Sanofi Live Attenuated Vaccines Product and Services
Table 36. Sanofi Live Attenuated Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sanofi Recent Developments/Updates
Table 38. Serum Institute Of India Basic Information, Manufacturing Base and Competitors
Table 39. Serum Institute Of India Major Business
Table 40. Serum Institute Of India Live Attenuated Vaccines Product and Services
Table 41. Serum Institute Of India Live Attenuated Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Serum Institute Of India Recent Developments/Updates
Table 43. Global Live Attenuated Vaccines Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 44. Global Live Attenuated Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 45. Global Live Attenuated Vaccines Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 46. Market Position of Manufacturers in Live Attenuated Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 47. Head Office and Live Attenuated Vaccines Production Site of Key Manufacturer
Table 48. Live Attenuated Vaccines Market: Company Product Type Footprint
Table 49. Live Attenuated Vaccines Market: Company Product Application Footprint
Table 50. Live Attenuated Vaccines New Market Entrants and Barriers to Market Entry
Table 51. Live Attenuated Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Live Attenuated Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 53. Global Live Attenuated Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 54. Global Live Attenuated Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 55. Global Live Attenuated Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 56. Global Live Attenuated Vaccines Average Price by Region (2019-2024) & (USD/Unit)
Table 57. Global Live Attenuated Vaccines Average Price by Region (2025-2030) & (USD/Unit)
Table 58. Global Live Attenuated Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 59. Global Live Attenuated Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 60. Global Live Attenuated Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Global Live Attenuated Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Global Live Attenuated Vaccines Average Price by Type (2019-2024) & (USD/Unit)
Table 63. Global Live Attenuated Vaccines Average Price by Type (2025-2030) & (USD/Unit)
Table 64. Global Live Attenuated Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 65. Global Live Attenuated Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 66. Global Live Attenuated Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 67. Global Live Attenuated Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 68. Global Live Attenuated Vaccines Average Price by Application (2019-2024) & (USD/Unit)
Table 69. Global Live Attenuated Vaccines Average Price by Application (2025-2030) & (USD/Unit)
Table 70. North America Live Attenuated Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 71. North America Live Attenuated Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 72. North America Live Attenuated Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 73. North America Live Attenuated Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 74. North America Live Attenuated Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 75. North America Live Attenuated Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 76. North America Live Attenuated Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 77. North America Live Attenuated Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Europe Live Attenuated Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 79. Europe Live Attenuated Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 80. Europe Live Attenuated Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 81. Europe Live Attenuated Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 82. Europe Live Attenuated Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 83. Europe Live Attenuated Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 84. Europe Live Attenuated Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Live Attenuated Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Live Attenuated Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 87. Asia-Pacific Live Attenuated Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 88. Asia-Pacific Live Attenuated Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 89. Asia-Pacific Live Attenuated Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 90. Asia-Pacific Live Attenuated Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 91. Asia-Pacific Live Attenuated Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 92. Asia-Pacific Live Attenuated Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 93. Asia-Pacific Live Attenuated Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 94. South America Live Attenuated Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 95. South America Live Attenuated Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 96. South America Live Attenuated Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 97. South America Live Attenuated Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 98. South America Live Attenuated Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 99. South America Live Attenuated Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 100. South America Live Attenuated Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America Live Attenuated Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa Live Attenuated Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 103. Middle East & Africa Live Attenuated Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 104. Middle East & Africa Live Attenuated Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 105. Middle East & Africa Live Attenuated Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 106. Middle East & Africa Live Attenuated Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 107. Middle East & Africa Live Attenuated Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 108. Middle East & Africa Live Attenuated Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Middle East & Africa Live Attenuated Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 110. Live Attenuated Vaccines Raw Material
Table 111. Key Manufacturers of Live Attenuated Vaccines Raw Materials
Table 112. Live Attenuated Vaccines Typical Distributors
Table 113. Live Attenuated Vaccines Typical Customers
LIST OF FIGURES
Figure 2. Global Live Attenuated Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Live Attenuated Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Bacterial Examples
Figure 5. Viral Examples
Figure 6. Global Live Attenuated Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Live Attenuated Vaccines Consumption Value Market Share by Application in 2023
Figure 8. Hospitals Examples
Figure 9. Clinics Examples
Figure 10. Research Institutes Examples
Figure 11. Others Examples
Figure 12. Global Live Attenuated Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Live Attenuated Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Live Attenuated Vaccines Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Live Attenuated Vaccines Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Live Attenuated Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Live Attenuated Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Live Attenuated Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Live Attenuated Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Live Attenuated Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Live Attenuated Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Live Attenuated Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Live Attenuated Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Live Attenuated Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Live Attenuated Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Live Attenuated Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Live Attenuated Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Live Attenuated Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Live Attenuated Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Live Attenuated Vaccines Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Live Attenuated Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Live Attenuated Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Live Attenuated Vaccines Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Live Attenuated Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Live Attenuated Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Live Attenuated Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Live Attenuated Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Live Attenuated Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Live Attenuated Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Live Attenuated Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Live Attenuated Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Live Attenuated Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Live Attenuated Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Live Attenuated Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Live Attenuated Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 54. China Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Live Attenuated Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Live Attenuated Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Live Attenuated Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Live Attenuated Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Live Attenuated Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Live Attenuated Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Live Attenuated Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Live Attenuated Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Live Attenuated Vaccines Market Drivers
Figure 75. Live Attenuated Vaccines Market Restraints
Figure 76. Live Attenuated Vaccines Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Live Attenuated Vaccines in 2023
Figure 79. Manufacturing Process Analysis of Live Attenuated Vaccines
Figure 80. Live Attenuated Vaccines Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 2. Global Live Attenuated Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Live Attenuated Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Bacterial Examples
Figure 5. Viral Examples
Figure 6. Global Live Attenuated Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Live Attenuated Vaccines Consumption Value Market Share by Application in 2023
Figure 8. Hospitals Examples
Figure 9. Clinics Examples
Figure 10. Research Institutes Examples
Figure 11. Others Examples
Figure 12. Global Live Attenuated Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Live Attenuated Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Live Attenuated Vaccines Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Live Attenuated Vaccines Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Live Attenuated Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Live Attenuated Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Live Attenuated Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Live Attenuated Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Live Attenuated Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Live Attenuated Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Live Attenuated Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Live Attenuated Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Live Attenuated Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Live Attenuated Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Live Attenuated Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Live Attenuated Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Live Attenuated Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Live Attenuated Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Live Attenuated Vaccines Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Live Attenuated Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Live Attenuated Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Live Attenuated Vaccines Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Live Attenuated Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Live Attenuated Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Live Attenuated Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Live Attenuated Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Live Attenuated Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Live Attenuated Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Live Attenuated Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Live Attenuated Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Live Attenuated Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Live Attenuated Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Live Attenuated Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Live Attenuated Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 54. China Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Live Attenuated Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Live Attenuated Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Live Attenuated Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Live Attenuated Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Live Attenuated Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Live Attenuated Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Live Attenuated Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Live Attenuated Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Live Attenuated Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Live Attenuated Vaccines Market Drivers
Figure 75. Live Attenuated Vaccines Market Restraints
Figure 76. Live Attenuated Vaccines Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Live Attenuated Vaccines in 2023
Figure 79. Manufacturing Process Analysis of Live Attenuated Vaccines
Figure 80. Live Attenuated Vaccines Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
More Publications
Global Life Sciences Electronic Batch Records Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
US$ 3,480.00
August 2018
123 pages
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Rotavirus Vaccines Market 2018, Forecast to 2023
US$ 4,880.00
July 2018
129 pages
Global Neuroendocrine Function Test Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
US$ 3,480.00
August 2018
115 pages
Global Clindamycin Phosphate Topical Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
US$ 3,480.00
June 2024
96 pages
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Vaccine Refrigerators Market 2018, Forecast to 2023
US$ 4,880.00
December 2018
147 pages
